1. Baseline characteristics of study participants.
| Characteristic | Placebo (n=2 257) | Aspirin (n=2 267) |
| Age (years) | 54.9±7.9 | 54.8±8.1 |
| Male | 89.4% | 88.4% |
| Ethnicity | ||
| White | 91.5% | 91.7% |
| Black | 5.9% | 6.3% |
| Hispanics | 2.6% | 2.0% |
| BMI | 26.0±3.5 | 25.9±3.5 |
| Diabetes | 2.8% | 2.5% |
| Smoking | ||
| Never | 27.2% | 27.5% |
| Former | 5.4% | 5.3% |
| Current | 19.2% | 19.7% |
| Alcohol consumption | ||
| Daily drink (>1.5 ounces) | 15.4% | 15.9% |
| Laboratory results | ||
| Platelet count (×109 /L) | 253±70 | 257±70 |
| AST (IU/L) | 32±34 | 31±15 |
| ALP (IU/L) | 62±22 | 64±23 |
| Bilirubin (mg/dL) | 0.7±0.3 | 0.7±0.3 |
| APRI | 0.34±0.46 | 0.33±0.22 |